▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

EARNINGS SUMMARY: Details of StemCells Inc Q4 Earnings Report

By RTTNews Staff Writer ✉ | Published: 3/23/2016 4:08 PM ET

Below are the earnings highlights for StemCells Inc (STEM):

-Earnings: -$8.12 million in Q4 vs. -$9.33 million in the same period last year.
-EPS: -$0.07 in Q4 vs. -$0.14 in the same period last year.
-Analysts projected -$0.06 per share
-Revenue: $0.03 million in Q4 vs. $0.88 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Biotech Stocks Facing FDA Decision In January 2022 PDUFA Cancers Rare Diseases HIV

Biotech Stocks Facing FDA Decision In January 2022

Latest Updates on COVID-19

U.S. Daily Covid Cases Cross 100K Mark For 10th Day This Month

U.S. Daily Covid Cases Cross 100K Mark Once Again

US Covid Daily Cases Cross 100K Mark For Fourth Consecutive Day

US Daily Covid Cases Cross 100K Mark For Seventh Day This Month

AstraZeneca: EU Approves Covid-19 Vaccine Vaxzevria As Third Dose Booster

Read More

COVID-19: Drugs in Development

RELATED NEWS

Stem, Inc. Q1 Loss Drops

Stem Q1 22 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Teva Pharma Recalls One Lot Of Anagrelide Capsules

US To Get About 2 Mln Infant Formula Cans From UK's Kendal Nutricare: FDA

Netflix Broadens Gaming Squad With 4 New Games On Mobile App

Multiple Products Containing Jif Peanut Butter Recalled

Walmart To Expand Drone Delivery Network To 34 Sites In Six States By Year End

Blue Moose Spinach Artichoke Parmesan Dip Recalled

Samsung Galaxy Watch4 Gets Google Assistant Support

Cargill Recalls Wilbur Chocolate Products With Jif Peanut Butter

FDA Approves Regeneron's Dupixent To Treat Eosinophilic Esophagitis

J. M. Smucker Recalls Select Jif Peanut Butter Products

Smithfield Recalls RTE Bacon Topping Products

Leoni AG Sells Automotive Cable Solutions Business To Thai Firm Stark Corp.

FDA Approves Regeneron's Dupixent To Treat Eosinophilic Esophagitis

NVIDIA Corporation Q1 Profit Decreases, but beats estimates

Teva: Study Finds Austedo Provided Improvements In TD-related Movements In Postmenopausal Women

Walmart, Symbotic Expand Commercial Deal To Implement Robotics And Software Automation Platform

Blue Moose Spinach Artichoke Parmesan Dip Recalled

Dermavant Sciences Says FDA Approves VTAMA Cream, 1% For Plaque Psoriasis In Adults

Hikma Pharma CEO Siggi Olafsson Resigns - Quick Facts

Stellantis And Samsung SDI To Invest More Than $2.5 Bln For Battery Plant In Indiana

Seagen Announces Positive Topline Results Of Phase 2 MOUNTAINEER Trial Of TUKYSA With Trastuzumab

TotalEnergies To Acquire 50% Of Clearway Energy Group; GIP Becomes Equity Partner In SunPower

Innoviva Agrees To Acquire Entasis Therapeutics For $2.20/Shr Cash

Cargill Recalls Wilbur Chocolate Products With Jif Peanut Butter

FAT Brands To Buy Nestlé Toll House Café By Chip Business From Crest Foods

Cable One To Additionally Buy Back Up To $450 Mln Of Shares

Aegon To Sell 50% Stake In Spanish JV With Liberbank To Unicaja Banco

Knorr-Bremse Shareholders Approve Proposed Dividend Of EUR 1.85/shr

General Mills To Sell Helper And Suddenly Salad Businesses To Eagle Family Foods Group

CD&R, TPG Capital To Acquire Covetrus

Walmart Pulls Juneteenth-Themed Ice Cream From Stores, Issues Apology

Aareal Bank: Atlantic BidCo's Takeover Offer Exceeds Minimum Acceptance Level Of 60%

IntegraFin Holdings H1 Group Revenue Grew 13%

Global Infrastructure Partners, TotalEnergies Form Partnership In U.S. Renewables

Hyundai Motor To Invest More Than $10 Bln In US By 2025